Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
618.00    5.00 (0.82%)
Bid:
617.00
Ask:
619.00
Spread: 2.00 (0.324%)
Market Cap: £685.83m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

Trading Update

2 Aug 2022 07:00

RNS Number : 5226U
Barr(A.G.) PLC
02 August 2022
Β 

IMMEDIATE RELEASE 2 August 2022

A.G. BARR p.l.c.

("A.G. BARR")

Β 

Strong H1 trading - full year in line with expectations

A.G. BARR p.l.c., which produces and markets some of the UK's leading drinks brands, including IRN-BRU, Rubicon and Funkin, today announces a trading update in respect of the 26 weeks ended 31 July 2022.Β 

We are pleased to report that revenue for the first half of the financial year is expected to be c.Β£157m.Β 

This represents year on year revenue growth of :

● c.19% on a like-for-like basis, excluding both the 27th week in prior year and the revenue contribution from MOMA Foods in the current reporting period

● c.16% on a reported revenue basis (27 weeks* to 1 August 2021 : Β£135.3m)Β 

This strong revenue performance reflects the continued positive momentum across all business units - Barr Soft Drinks, Funkin and MOMA. Our growth has been driven by ongoing brand investment and the successful execution of our pricing and promotional activity. Trading performance further benefited from the year on year Covid recovery across the market, particularly in the on-trade and out of home sectors, as well as the exceptional British summer weather in recent weeks.

Outlook We anticipate that the UK's current high level of inflation will continue across the balance of the year, with economic conditions becoming increasingly challenging for consumers and industry alike. Across the second half of the financial year we will continue to invest behind our brands and believe that our strategy will support continued growth. At the same time we will take appropriate mitigating action to limit the full year impact of cost inflation.Β 

Roger White, Chief Executive, commented:

"Our brands are performing well and our business has continued to demonstrate both its resilience and flexibility. While not immune to the current cost inflationary pressures experienced across the UK, looking forward into the second half of the financial year, we remain confident of delivering a full-year profit performance ahead of the prior year and in line with board expectations."

For more information, please contact :

A.G. BARR 0330 390 3900 Instinctif PartnersΒ  020 7457 2010/05

Roger White, Chief Executive Justine Warren

Stuart Lorimer, Finance Director Matthew Smallwood

Next update : Interim Results - September 2022

* 2021/22 was a 53-week financial year with a 27-week first half. 2022/23 reverts to a 52-week year with a 26-week first half

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTUPURCRUPPGQG
Date   Source Headline
9th Jun 20262:00 pmRNSDirector/PDMR Shareholding
9th Jun 20262:00 pmRNSDirector/PDMR Shareholding
8th Jun 20263:00 pmRNSDirector/PDMR Shareholding
5th Jun 20261:00 pmRNSDirector/PDMR Shareholding
3rd Jun 20267:00 amRNS-RLaunch of IRN-BRU Summer Campaign
27th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20261:30 pmRNSDirector/PDMR Shareholding
22nd May 20262:00 pmRNSResult of AGM
11th May 20262:46 pmRNSDirector/PDMR Shareholding
21st Apr 202610:43 amRNSAnnual Report and Accounts and Notice of AGM
16th Apr 20267:00 amRNSDirector/PDMR Shareholding
14th Apr 20267:00 amRNSDirector/PDMR Shareholding
13th Apr 20269:39 amRNSDirector/PDMR Shareholding
7th Apr 202611:21 amRNSDirector/PDMR Shareholding
1st Apr 20268:44 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSFinal Results
23rd Mar 20267:00 amRNS-RLaunch of IRN-BRU 'ZERO'
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSNotice of Results Presentation
9th Feb 20263:56 pmRNSDirector/PDMR Shareholding
4th Feb 20264:16 pmRNSHolding(s) in Company
3rd Feb 20267:00 amRNSFull Year Trading Update
15th Jan 20267:00 amRNSDirectorate change
12th Jan 202611:00 amRNSDirector/PDMR Shareholding
8th Dec 20252:49 pmRNSDirector/PDMR Shareholding
19th Nov 20251:44 pmRNSHolding(s) in Company
17th Nov 20253:25 pmRNSDirector/PDMR Shareholding
10th Nov 20254:44 pmRNSDirector/PDMR Shareholding
10th Nov 20254:38 pmRNSDirector/PDMR Shareholding
8th Oct 20252:39 pmRNSDirector/PDMR Shareholding
30th Sep 20257:00 amRNSInterim Results
11th Sep 20252:00 pmRNSNotice of Results
10th Sep 20256:00 pmRNSDirector/PDMR Shareholding
28th Aug 20252:00 pmRNS2025 Annual General Meeting Update
12th Aug 20254:01 pmRNSDirector/PDMR Shareholding
1st Aug 20257:01 amRNSDirector Declaration
29th Jul 20257:00 amRNSTrading Statement
9th Jul 202511:00 amRNSAppointment of Non-Executive Director
8th Jul 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jul 202511:09 amRNSDirector/PDMR Shareholding
11th Jun 202511:01 amRNSDirector/PDMR Shareholding
10th Jun 20254:20 pmRNSDirector/PDMR Shareholding
10th Jun 20252:02 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:00 amRNSCapital Markets Event
23rd May 20255:36 pmRNSResult of AGM
12th May 20251:54 pmRNSDirector/PDMR Shareholding
30th Apr 20259:15 amRNSPotential disposal of Strathmore Business
28th Apr 20253:16 pmRNSDirector/PDMR Shareholding
28th Apr 20253:15 pmRNSDirector/PDMR Shareholding
22nd Apr 202510:24 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.